Annual SG&A
$3.55 M
0.00%
01 December 2023
Summary:
Cadrenal Therapeutics Common Stock annual selling, general & administrative expenses is currently $3.55 millionCVKD annual SG&A is now at all-time high.CVKD Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.67 M
+$462.50 K+38.15%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock quarterly selling, general & administrative expenses is currently $1.67 million, with the most recent change of +$462.50 thousand (+38.15%) on 01 September 2024. Over the past year, it has increased by +$776.80 thousand (+86.49%). CVKD quarterly SG&A is now at all-time high.CVKD Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$72.47 M
-$7.61 M-11.73%
01 September 2024
Summary:
Cadrenal Therapeutics Common Stock TTM selling, general & administrative expenses is currently -$72.47 million, with the most recent change of -$7.61 million (-11.73%) on 01 September 2024. Over the past year, it has dropped by -$75.12 million (-2837.38%). CVKD TTM SG&A is now -10576.09% below its all-time high of $4.92 million, reached on 01 September 2024.CVKD TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CVKD Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +86.5% | -2837.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CVKD Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | at low | at high | +996.9% | <-9999.0% | at low |
| 5 y | 5 years | at high | at low | at high | +996.9% | <-9999.0% | at low |
| alltime | all time | at high | at low | at high | +996.9% | <-9999.0% | at low |
Cadrenal Therapeutics Common Stock Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.67 M(+38.1%) | $4.92 M(+18.8%) |
| June 2024 | - | $1.21 M(+7.7%) | $4.14 M(+11.5%) |
| Mar 2024 | - | $1.13 M(+24.8%) | $3.71 M(+4.5%) |
| Dec 2023 | $3.55 M | $902.10 K(+0.4%) | $3.55 M(+34.1%) |
| Sept 2023 | - | $898.10 K(+14.5%) | $2.65 M(-0.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $784.60 K(-18.7%) | $2.67 M(+23.3%) |
| Mar 2023 | - | $964.70 K(+5.3%) | $2.16 M(+60.2%) |
| Sept 2022 | - | $915.90 K(+227.0%) | $1.35 M(+211.6%) |
| June 2022 | - | $280.10 K(+83.4%) | $432.80 K(+183.4%) |
| Mar 2022 | - | $152.70 K | $152.70 K |
FAQ
- What is Cadrenal Therapeutics Common Stock annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock quarterly SG&A year-on-year change?
- What is Cadrenal Therapeutics Common Stock TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Cadrenal Therapeutics Common Stock?
- What is Cadrenal Therapeutics Common Stock TTM SG&A year-on-year change?
What is Cadrenal Therapeutics Common Stock annual selling, general & administrative expenses?
The current annual SG&A of CVKD is $3.55 M
What is the all time high annual SG&A for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high annual selling, general & administrative expenses is $3.55 M
What is Cadrenal Therapeutics Common Stock quarterly selling, general & administrative expenses?
The current quarterly SG&A of CVKD is $1.67 M
What is the all time high quarterly SG&A for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high quarterly selling, general & administrative expenses is $1.67 M
What is Cadrenal Therapeutics Common Stock quarterly SG&A year-on-year change?
Over the past year, CVKD quarterly selling, general & administrative expenses has changed by +$776.80 K (+86.49%)
What is Cadrenal Therapeutics Common Stock TTM selling, general & administrative expenses?
The current TTM SG&A of CVKD is -$72.47 M
What is the all time high TTM SG&A for Cadrenal Therapeutics Common Stock?
Cadrenal Therapeutics Common Stock all-time high TTM selling, general & administrative expenses is $4.92 M
What is Cadrenal Therapeutics Common Stock TTM SG&A year-on-year change?
Over the past year, CVKD TTM selling, general & administrative expenses has changed by -$75.12 M (-2837.38%)